Literature DB >> 23096729

[Whole Body Magnetic Resonance and CT/PET in patients affected by multiple myeloma during staging before treatment].

Carmela Falcone1, Stefania Cipullo, Pasqualina Sannino, Antonio Restuccia.   

Abstract

The diagnostic imaging plays a pivotal role in the staging of multiple myeloma (MM). Traditional imaging techniques allow a precise disease extension before treatment, but some drawbacks have been demonstrated after treatment. WBMRI and CT/PET represent alterative procedures during staging, but few comparative data are available to date. Aim of our study was to estimate the diagnostic accuracy of WB-MRI and CT/PET in 28 consecutive patients affected by MM before therapy. CT/PET was positive in 22/28 patients, whereas WB-MRI correctly identified 100% of patients. In this setting of patients WB MRI have demonstrated to be superior respect to CT/PET in term of diagnostic accuracy, especially when a diffuse disease is detected with a bone marrow aspiration with more than 40% of plasma cells. WBMRI shows a diagnostic accuracy higher than FDG-CT/PET in staging especially when diffuse. However a whole body coverage is crucial to properly manage MM patients irrespective of which technique is used.

Entities:  

Mesh:

Year:  2012        PMID: 23096729     DOI: 10.1701/1166.12886

Source DB:  PubMed          Journal:  Recenti Prog Med        ISSN: 0034-1193


  3 in total

1.  Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

Authors:  Cristina Nanni; Annibale Versari; Stephane Chauvie; Elisa Bertone; Andrea Bianchi; Marco Rensi; Marilena Bellò; Andrea Gallamini; Francesca Patriarca; Francesca Gay; Barbara Gamberi; Pietro Ghedini; Michele Cavo; Stefano Fanti; Elena Zamagni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-21       Impact factor: 9.236

2.  Diagnostic performance of 18F-FDG PET/CT and whole-body MRI before and early after treatment of multiple myeloma: a prospective comparative study.

Authors:  Mohammad Abd Alkhalik Basha; Maged Abdel Gelil Hamed; Rania Refaat; Mohamad Zakarya AlAzzazy; Manar A Bessar; Elshaimaa Mohamed Mohamed; Ayman F Ahmed; Heba Fathy Tantawy; Khaled Mohamed Altaher; Ahmed Ali Obaya; Amira Hamed Mohamed Afifi
Journal:  Jpn J Radiol       Date:  2018-04-18       Impact factor: 2.374

Review 3.  Therapy assessment in multiple myeloma with PET.

Authors:  Cristina Nanni; Elena Zamagni
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-01       Impact factor: 9.236

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.